MPO and hemorrhage: Furthermore, administration of the p38 MAPK inhibitor SB-203580 prevented the osthole-mediated attenuation of hepatic MPO activity after trauma-hemorrhage [0.453±0.039 (osthole + SB-203580) vs. 0.277±0.023 (osthole) U/mg protein, p<0.05].